Investor Alert

Gilead Sciences Inc.



After Hours

 --Quotes are delayed by 20 min

Jan 28, 2022, 7:59 p.m.





+0.14 +0.20%


Volume 298,091

Quotes are delayed by 20 min


Previous close

$ 67.27

$ 68.86


+1.59 +2.36%

Day low

Day high




52 week low

52 week high




Annual Financials for Gilead Sciences Inc.

Fiscal year is January-December. All values USD millions. 20162017201820192020 5-year trend
Sales/Revenue 30.32B26.14B22.21B22.32B24.64B
Cost of Goods Sold (COGS) incl. D&A 4.4B4.51B4.85B4.68B4.51B
COGS excluding D&A 3.24B3.23B3.42B3.27B3.03B
Depreciation & Amortization Expense 1.16B1.29B1.43B1.4B1.48B
Depreciation 177M233M226M255M288M
Amortization of Intangibles 981M1.05B1.2B1.15B1.19B
Gross Income 25.92B21.62B17.36B17.65B20.13B
20162017201820192020 5-year trend
SG&A Expense 7.93B7.3B8.25B12.69B9.69B
Research & Development 4.67B3.56B4.2B8.31B4.86B
Other SG&A 3.26B3.74B4.06B4.38B4.83B
Other Operating Expense -----
Unusual Expense 258M244M707M(422M)2.94B
EBIT after Unusual Expense (258M)14.08B8.4B5.38B7.5B
Non Operating Income/Expense 327M567M476M773M(4.85B)
Non-Operating Interest Income -----
Equity in Affiliates (Pretax) -----
Interest Expense 964M1.12B1.08B995M984M
Gross Interest Expense 964M1.12B1.08B995M984M
Interest Capitalized -----
Pretax Income 17.1B13.53B7.8B5.16B1.67B
Income Tax 3.61B8.89B2.34B(204M)1.58B
Income Tax - Current Domestic 3.48B8.91B1.88B1.78B1.65B
Income Tax - Current Foreign 261M54M175M124M155M
Income Tax - Deferred Domestic (57M)(143M)307M(885M)(261M)
Income Tax - Deferred Foreign (77M)60M(21M)(1.22B)38M
Income Tax Credits -----
Equity in Affiliates -----
Other After Tax Income (Expense) -----
Consolidated Net Income 13.49B4.64B5.46B5.36B89M
Minority Interest Expense (13M)16M5M(22M)(34M)
Net Income 13.5B4.63B5.46B5.39B123M
Extraordinaries & Discontinued Operations -----
Extra Items & Gain/Loss Sale Of Assets -----
Cumulative Effect - Accounting Chg -----
Discontinued Operations -----
Net Income After Extraordinaries 13.5B4.63B5.46B5.39B123M
Preferred Dividends -----
Net Income Available to Common 13.5B4.63B5.46B5.39B123M
EPS (Basic) 10.083.544.204.240.10
Basic Shares Outstanding 1.34B1.31B1.3B1.27B1.26B
EPS (Diluted) 9.943.514.174.220.10
Diluted Shares Outstanding 1.36B1.32B1.31B1.28B1.26B
EBITDA 19.15B15.61B10.54B6.36B11.92B
Link to MarketWatch's Slice.